Bio-Techne (TECH) Stock
Fundamentals
Latest news
About Bio-Techne
Bio-Techne Corporation is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment.
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Kim Kelderman | CEO, President & Director | 1968 |
| Mr. James T. Hippel CPA | Executive VP of Finance & CFO | 1971 |
| Mr. Shane V. Bohnen | Senior VP, General Counsel, Corporate Secretary & Chief Sustainability Officer | 1975 |
| Mr. William A. Geist | President of Protein Sciences Segment | 1969 |
| Dr. Gary J. Latham Ph.D. | VP & CTO | — |
| Mr. David Clair C.F.A. | Vice President of Investor Relations | — |
| Mr. Martin Wirtz | Senior Vice President of Strategy & Corporate Development | — |
| Ms. Cheryl Bethune | Senior VP & Chief Human Resources Officer | — |
| Mr. Luca Cicchetti | Managing Director | — |
| Mr. Steven C. Crouse | President of Diagnostics & Spatial Biology Segment | 1973 |



